RARE ALERT: Paratek Pharmaceuticals said to ... - Part 2

Gurnet Point Capital is said to be one of the private equity firms that has been circling Paratek Pharmaceuticals, the US-listed biopharmaceutical company.

Earlier this year Betaville Intelligence reported that Paratek Pharmaceuticals may have attracted takeover interest from a private equity suitor.

People following the situation said Gurnet Point Capital has been studying the purchase of Paratek Pharmaceuticals...